Kymera Therapeutics Inc (KYMR)
EBITDA
-$59.10M
Quarterly · Period ending: · USD
KYMR EBITDA
Latest reported-$59.10Mperiod ending
Latest reported-$59.10Mperiod ending
KYMR Quarterly EBITDA (-$11.26M → -$59.10M)
Quarterly EBITDA
High-resolution chart · PNG
KYMR ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -59,100,000 | |
| -67,151,000 | |
| -85,152,000 | |
| -80,026,000 | |
| -74,422,000 | |
| -63,461,000 | |
| -68,706,000 | |
| -60,440,000 | |
| -40,063,000 | |
| -47,027,000 | |
| -13,425,000 | |
| -51,931,000 | |
| -37,851,000 | |
| -39,994,000 | |
| -33,989,000 | |
| -42,199,000 | |
| -39,511,000 | |
| -35,956,000 | |
| -33,162,000 | |
| -27,841,000 | |
| -24,080,000 | |
| -12,566,000 | |
| -12,161,000 | |
| -7,468,000 | |
| -13,575,000 | |
| -10,511,000 | |
| -11,122,000 | |
| -11,258,000 |